Literature DB >> 16857565

Plasma Abeta in Alzheimer's disease--up or down?

Henrik Zetterberg, Kaj Blennow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16857565     DOI： 10.1016/S1474-4422(06)70503-8

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  12 in total

1.  Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease.

Authors:  Victor L Villemagne; Keyla A Perez; Kerryn E Pike; W Mei Kok; Christopher C Rowe; Anthony R White; Pierrick Bourgeat; Olivier Salvado; Justin Bedo; Craig A Hutton; Noel G Faux; Colin L Masters; Kevin J Barnham
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

2.  Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment.

Authors:  K Blennow; G De Meyer; O Hansson; L Minthon; A Wallin; H Zetterberg; P Lewczuk; H Vanderstichele; E Vanmechelen; J Kornhuber; J Wiltfang; I Heuser; W Maier; C Luckhaus; E Rüther; M Hüll; H Jahn; H J Gertz; L Frölich; H Hampel; R Pernetzki
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

3.  The relationship between plasma amyloid-β peptides and the medial temporal lobe in the homebound elderly.

Authors:  Xiaoyan Sun; Rafeeque Bhadelia; Elizabeth Liebson; Peter Bergethon; Marshal Folstein; Jay-Jiguang Zhu; D Mkaya Mwamburi; Samuel Patz; Wei Qiao Qiu
Journal:  Int J Geriatr Psychiatry       Date:  2010-12-09       Impact factor: 3.485

4.  Nonobese Male Patients with Alzheimer's Disease Are Vulnerable to Decrease in Plasma Leptin.

Authors:  Jing Tian; Tienju Wang; Kun Jia; Lan Guo; Russell H Swerdlow; Heng Du
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

5.  Amyloid-associated depression: a prodromal depression of Alzheimer disease?

Authors:  Xiaoyan Sun; David C Steffens; Rhoda Au; Marshal Folstein; Paul Summergrad; Jacqueline Yee; Irwin Rosenberg; D Mkaya Mwamburi; Wei Qiao Qiu
Journal:  Arch Gen Psychiatry       Date:  2008-05

Review 6.  Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.

Authors:  Christopher D Aluise; Renã A Sowell; D Allan Butterfield
Journal:  Biochim Biophys Acta       Date:  2008-08-07

7.  Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.

Authors:  Xiaoyan Sun; Chi Chia Chiu; Elizabeth Liebson; Natalia A Crivello; Lixia Wang; Joshua Claunch; Marshal Folstein; Irwin Rosenberg; D Mkaya Mwamburi; Inga Peter; Wei Qiao Qiu
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jul-Sep       Impact factor: 2.703

8.  Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease.

Authors:  Qiushan Tao; Haihao Zhu; Xi Chen; Robert A Stern; Neil Kowall; Rhoda Au; Jan Krzysztof Blusztajn; Wei Qiao Qiu
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

9.  Biofunctionalized magnetic nanoparticles for specifically detecting biomarkers of Alzheimer's disease in vitro.

Authors:  Che-Chuan Yang; Shieh-Yueh Yang; Jen-Jie Chieh; Herng-Er Horng; Chin-Yih Hong; Hong-Chang Yang; K H Chen; B Y Shih; Ta-Fu Chen; Ming-Jang Chiu
Journal:  ACS Chem Neurosci       Date:  2011-05-30       Impact factor: 4.418

Review 10.  Biological markers for early detection and pharmacological treatment of Alzheimer's disease.

Authors:  Harald Hampel; Karl Broich; Yvonne Hoessler; Johannes Pantel
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.